In-hospital initiation of PCSK9 inhibitors in ACS: pros and cons.
EuroIntervention
; 19(4): e283-e285, 2023 07 17.
Article
in En
| MEDLINE
| ID: mdl-37458121
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/
PCSK9 Inhibitors
Limits:
Humans
Language:
En
Journal:
EuroIntervention
Year:
2023
Document type:
Article